HBIO
Harvard Bioscience·NASDAQ
--
--(--)
--
--(--)
HBIO fundamentals
Harvard Bioscience (HBIO) Revenue Breakdown: Q3 2025 Business & Regional Performance
Harvard Bioscience (HBIO) reported total revenue of 20.59M USD in Q3 2025, with its core business segment Instruments, Equipment, Software and Accessories contributing 90.24%. Regionally, Americas remained the largest market, accounting for 50.70% of total revenue. Explore Harvard Bioscience's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Harvard Bioscience (HBIO) reported total revenue of 20.59M USD in Q3 2025, with its core business segment Instruments, Equipment, Software and Accessories contributing 90.24%. Regionally, Americas remained the largest market, accounting for 50.70% of total revenue. Explore Harvard Bioscience's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What guidance did Harvard Bioscience's management provide for the next earnings period?Did Harvard Bioscience beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Harvard Bioscience year over year?What is the market's earnings forecast for Harvard Bioscience next quarter?What were the key takeaways from Harvard Bioscience's earnings call?What were the key takeaways from Harvard Bioscience’s earnings call?What is Harvard Bioscience's gross profit margin?What is Harvard Bioscience's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
